Search for: "King et al v. Wyeth et al"
Results 1 - 12
of 12
Sorted by Relevance
|
Sort by Date
2 Apr 2007, 9:52 pm
Effexor XR: Wyeth v. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Effexor (Venlafaxine) – US: Sandoz loses motion for interlocutory appeal in Effexor patent suit with Wyeth (Patent Docs) EpiPen Auto-Injector (Epinephrine) – US: Patent infringement complaint following a Paragraph IV certification: King Pharmaceuticals, Inc. et al. v. [read post]
18 Apr 2006, 8:28 am
The other is a decision in the King v. [read post]
24 Aug 2007, 1:14 am
Neil Kramer et al. [read post]
4 Mar 2010, 8:13 am
Alveda King et al. [read post]
14 Nov 2007, 8:59 pm
Actavis et al.; v. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
9 Aug 2012, 5:00 am
Wyeth (hormone therapy) Trial2007-04-19 Simon v. [read post]
2 Mar 2012, 6:52 am
Wyeth (hormone therapy) Trial2007-04-19 Simon v. [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
25 Apr 2015, 11:03 am
., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
21 Nov 2008, 1:36 pm
(IPKat) EU favours disclosure of computer patents before standards are set (Intellectual Property Watch) Trade Marks Court of First Instance finds RAUTARUUKKI fails to satisfy acquired distinctiveness criterion: Rautaruukki Oyj v OHIM (Class 46) Court of First Instance finds original signature of famous Italian lutist Antonio Stradivari, in arte Stradivarius, of the 17th century, cannot be read by relevant consumers: T‑340/06 (Catch Us If You Can!!!) [read post]
